Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05141266 · ClinicalTrials.gov registry record · NA

Healthy Opioid Prescription Engagement

A NA study of Opioid-Related Disorders and Opioid Misuse, sponsored by Jerry Cochran.

Active
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT05141266 is a NA study of Opioid-Related Disorders and Opioid Misuse that is active but no longer recruiting, run by Jerry Cochran. The registered enrollment target is 350 participants, roughly in line with the 339-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05141266, a NA study of Opioid-Related Disorders and Opioid Misuse, is active but no longer recruiting, sponsored by Jerry Cochran.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial across 14 community pharmacies to test the efficacy of the Brief Intervention-Medication Therapy Management intervention (BI-MTM). The establishment of the BI-MTM model will result in a major impact for addressing the opioid epidemic, preventing opioid use disorder and overdose, and safeguarding patient health in a novel community-based service setting.

Interventions

  • BEHAVIORAL Patient Navigation
  • OTHER Standard Medication Counseling (SMC)

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2021-11-08
Est. Completion 2026-07-01
Phase NA

Sponsor

Jerry Cochran

2 total trials

What the Registry Record Tells You About NCT05141266

The ClinicalTrials.gov registry entry for NCT05141266 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 339-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target. The listed sponsor is Jerry Cochran, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigation is the first listed.

NCT05141266 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05141266 about?

NCT05141266 is a clinical study titled "Healthy Opioid Prescription Engagement". This study is a randomized controlled trial across 14 community pharmacies to test the efficacy of the Brief Intervention-Medication Therapy Management intervention (BI-MTM). The establishment of the BI-MTM model will result in a major impact for addressing the opioid epidemic, preventing opioid use...

What is the current status of trial NCT05141266?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2021-11-08. Estimated completion is 2026-07-01.

What conditions does trial NCT05141266 study?

This clinical trial studies the following conditions: Opioid-Related Disorders, Opioid Misuse, Pharmacist-Patient Relations.

What interventions are being tested in trial NCT05141266?

The interventions under investigation include: Patient Navigation (BEHAVIORAL), Standard Medication Counseling (SMC) (OTHER).

Who is sponsoring clinical trial NCT05141266?

This trial is sponsored by Jerry Cochran, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05141266 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.